Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
COSMO Pharmaceuticals N.V. ( (CH:COPN) ) has shared an update.
Cosmo Pharmaceuticals will showcase its real-time medical AI capabilities at NVIDIA GTC 2026 in San Jose, highlighting its role in developing AI systems used during clinical procedures. The company will present a session titled “Engineering Medical Grade Platforms for Real Time AI,” led by senior MedTech AI leaders, outlining how its platforms assist physicians with detection, decision-making and workflow optimization.
By emphasizing products like GI Genius and its use of NVIDIA’s accelerated computing technologies, Cosmo aims to demonstrate how medical-grade AI can deliver measurable value in routine care. The appearance at NVIDIA’s flagship AI conference reinforces Cosmo’s commitment to advancing AI in healthcare and strengthens its positioning as a key player at the convergence of medical technology and artificial intelligence.
The most recent analyst rating on (CH:COPN) stock is a Hold with a CHF93.00 price target. To see the full list of analyst forecasts on COSMO Pharmaceuticals N.V. stock, see the CH:COPN Stock Forecast page.
More about COSMO Pharmaceuticals N.V.
Cosmo Pharmaceuticals is a Dublin-based life-science company focused on MedTech AI, dermatology, gastrointestinal diseases and contract development and manufacturing. It designs, develops and manufactures advanced medical solutions, including AI-assisted platforms like GI Genius, serving global pharma, MedTech partners, patients and healthcare providers from hubs in Europe and the U.S.
Founded in 1997, Cosmo positions itself at the intersection of science and technology with a mission to improve standards of care and empower patients and clinicians. Its technologies are used in real-world clinical settings, reflecting a strategy to move innovations from research into everyday medical practice and build long-term confidence in healthcare delivery.
YTD Price Performance: -17.30%
Average Trading Volume: 61,422
Technical Sentiment Signal: Buy
Current Market Cap: CHF1.46B
See more insights into COPN stock on TipRanks’ Stock Analysis page.